Cyclobenzaprine is the most studied muscle relaxant for fibromyalgia and the one with the strongest evidence behind it. In meta-analyses, patients taking cyclobenzaprine were three times as likely to report overall improvement compared to placebo, with the most notable benefits in pain reduction and sleep quality. That said, no muscle relaxant is a standalone solution for fibromyalgia, and the best choice depends on which symptoms bother you most and how you tolerate side effects.
Why Muscle Relaxants Help in Fibromyalgia
Fibromyalgia isn’t primarily a muscle problem. It’s a condition of amplified pain signaling in the central nervous system, sometimes called nociplastic pain. Your brain and spinal cord process pain signals with the volume turned up, so stimuli that wouldn’t normally hurt become painful.
Muscle relaxants work in fibromyalgia not because they relax muscles in the traditional sense, but because they boost levels of calming brain chemicals like serotonin, norepinephrine, and GABA. These chemicals help dial down that overactive pain signaling. Since muscle tightness and spasm are also common in fibromyalgia, the direct muscle-relaxing effect provides a second layer of relief for many people.
Cyclobenzaprine: The Strongest Evidence
Cyclobenzaprine is structurally similar to older tricyclic antidepressants, which partly explains why it works beyond simple muscle relaxation. A meta-analysis of clinical trials found that for every five patients treated with cyclobenzaprine, one experienced meaningful symptom improvement. Pain improved relatively early in treatment, and sleep quality showed moderate improvement as well. The drug did not, however, reduce fatigue or the number of tender points.
The FDA approved a low-dose sublingual form of cyclobenzaprine specifically for fibromyalgia in recent years. The dosing starts at 2.8 mg once daily at bedtime for two weeks, then increases to 5.6 mg. This is significantly lower than the doses used for acute muscle spasms, which helps limit side effects while targeting the sleep and pain cycle that drives so much of fibromyalgia’s misery.
The main downside is sedation. Cyclobenzaprine is one of the more sedating muscle relaxants available, which makes it useful at bedtime but problematic if you need daytime relief. Dry mouth, dizziness, and tongue numbness (with the sublingual form) are also common. In clinical trials of cyclobenzaprine for fibromyalgia, the rate of adverse effects varied widely, with some studies reporting side effects in nearly all participants.
How Cyclobenzaprine Compares to Amitriptyline
Amitriptyline, a tricyclic antidepressant, is often prescribed for fibromyalgia pain and shares a similar chemical structure with cyclobenzaprine. A head-to-head trial found both drugs effective in the short term for a small percentage of fibromyalgia patients, with neither showing a clear advantage over the other. Long-term benefits were harder to confirm because of a strong placebo response in the study. In practice, doctors sometimes choose between the two based on side effect profiles and whether sleep disturbance or mood symptoms are the bigger concern.
Tizanidine and Baclofen: Other Options
Tizanidine is another sedating muscle relaxant sometimes prescribed for fibromyalgia. It works through a different pathway than cyclobenzaprine, acting on receptors in the spinal cord that reduce muscle tone and pain signaling. It’s similarly sedating, which limits daytime use, but some patients tolerate it better. The evidence base for tizanidine in fibromyalgia is thinner than for cyclobenzaprine, and systematic reviews have not found consistent benefits across studies.
Baclofen targets GABA receptors concentrated in the spinal cord. Its strongest evidence in fibromyalgia relates to sleep rather than pain. It can decrease the time it takes to fall asleep and increase deep, restorative sleep. For patients whose primary complaint is unrefreshing sleep and nighttime stiffness, baclofen may be worth discussing, though it’s not commonly a first-line choice.
Less Sedating Alternatives
If drowsiness is a dealbreaker, methocarbamol and metaxalone are the least sedating muscle relaxants available. The tradeoff is that evidence supporting their use specifically in fibromyalgia is limited. The American Academy of Family Physicians notes that these options may be useful for patients who can’t tolerate the sedation from cyclobenzaprine or tizanidine, but they haven’t been well studied for this condition. They’re more commonly used for acute back spasms than for chronic pain syndromes.
Limitations of Long-Term Use
Most clinical guidelines recommend muscle relaxants for no more than two to three weeks, based on the available evidence. That creates a tension with fibromyalgia, which is a chronic condition. A systematic review in JAMA Network Open found that long-term studies of muscle relaxants for fibromyalgia showed inconsistent results. Some found small benefits, others found none, and the overall picture did not clearly support ongoing use.
Central nervous system side effects accumulate with prolonged use. Drowsiness, dizziness, and cognitive fog can worsen quality of life in a condition that already causes those symptoms. There’s also a safety concern for people taking opioids: research suggests that roughly 30% of opioid users are also prescribed muscle relaxants, a combination that significantly increases the risk of overdose, especially with longer treatment durations. No studies have specifically measured misuse or dependence with muscle relaxants in fibromyalgia populations, so that risk remains poorly defined.
Where Muscle Relaxants Fit in Treatment
The European Alliance of Associations for Rheumatology places exercise as the only treatment with strong evidence for fibromyalgia. Medications, including muscle relaxants, receive a weaker recommendation and are suggested primarily for severe pain or sleep disturbance that hasn’t responded to non-drug approaches like physical activity, education, and psychological therapies. The guidelines emphasize a graduated, individualized approach built on shared decision-making.
In practical terms, this means muscle relaxants work best as one piece of a broader plan. Cyclobenzaprine taken at bedtime can improve sleep quality enough to make daytime exercise more feasible, creating a positive cycle. But relying on a muscle relaxant alone, without addressing the central nervous system changes driving the condition, typically produces modest and sometimes temporary results. If cyclobenzaprine helps your sleep and reduces your pain enough to stay active, it’s doing its job. If it’s not making a noticeable difference within a few weeks, the benefit is unlikely to emerge with continued use.